Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Excessive iron absorption is one of the main features of β-thalassemia and can lead to severe morbidity and mortality. Serial analyses of β-thalassemic mice indicate that while hemoglobin levels decrease over time, the concentration of iron in the liver, spleen, and kidneys markedly increases. Iron overload is associated with low levels of hepcidin, a peptide that regulates iron metabolism by triggering degradation of ferroportin, an iron-transport protein localized on absorptive enterocytes as well as hepatocytes and macrophages. Patients with β-thalassemia also have low hepcidin levels. These observations led us to hypothesize that more iron is absorbed in β-thalassemia than is required for erythropoiesis and that increasing the concentration of hepcidin in the body of such patients might be therapeutic, limiting iron overload. Here we demonstrate that a moderate increase in expression of hepcidin in β-thalassemic mice limits iron overload, decreases formation of insoluble membrane-bound globins and reactive oxygen species, and improves anemia. Mice with increased hepcidin expression also demonstrated an increase in the lifespan of their red cells, reversal of ineffective erythropoiesis and splenomegaly, and an increase in total hemoglobin levels. These data led us to suggest that therapeutics that could increase hepcidin levels or act as hepcidin agonists might help treat the abnormal iron absorption in individuals with β-thalassemia and related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since hepcidin arises as a key iron-regulated gene due to its function as a sensor for systemic iron availability, several strategies are envisioned to manipulate its expression [81].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [81]
In the citing paper
“Thus, transgenic expression of hepcidin prevented iron overload in Hfe−∕− (Nicolas et al., 2003) and Hbbth3∕+ (Gardenghi et al., 2010) mice, models of HH and β-thalassemia intermedia, respectively.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Gardenghi et al., 2010
In the citing paper
“Moreover, manipulation of hepcidin levels by these strategies also improved erythropoiesis in Hbbth3∕+ mice (Gardenghi et al., 2010; Nai et al., 2012).”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Gardenghi et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Self-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 3×
“Similarly, low HAMP levels have been measured in the urine of patients with β-thalassemia (15), further supporting this hypothesis.”
BackgroundPigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“In the latter group of mice, egress of iron from macrophages was not expected to be altered since Hamp1 is extremely low under conditions of iron deficiency (17).”
BackgroundLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 3×
“Similarly, low HAMP levels have been measured in the urine of patients with β-thalassemia (15), further supporting this hypothesis.”
BackgroundChen, K., Liu, J., Heck, S., Chasis, J. A., An, X., & Mohandas, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909296106 · Cited by 524 · cited 14×
“This assay allows the separation of erythroid cells into distinct populations corresponding to proerythroblasts (fraction I), basophilic (II), polychromatic (III), orthochromatic cells, and reticulocytes (IV), and mature rbc (V) (Supplemental Figure 6, only spleen is shown; similar results were observed in the BM) (18…”
MethodResultInfluentialSelf-citationMcEwen, E., Kedersha, N., Song, B., Scheuner, D., Gilks, N., Han, A., Chen, J.-J., Anderson, P., & Kaufman, R. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412882200 · Cited by 447 · cited 1×
“Previously presented data demonstrate that the absence of heme-regulated inhibitor (HRI) kinase, which controls Hb synthesis (25), exacerbates the β-thalassemia phenotype (26), while lack of heme exporter feline leukemia virus subgroup C cellular receptor (FLVCR), which controls heme export (27), impairs rbc formation…”
BackgroundHepcidin in iron overload disorders
Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y. P., Sakellaropoulos, N., Ganz, T., & Nemeth, E. (2005) · Blood · doi:10.1182/blood-2004-12-4844 · Cited by 445 · cited 1×
“Similarly, low HAMP levels have been measured in the urine of patients with β-thalassemia (15), further supporting this hypothesis.”
BackgroundSelf-citationDisorders of hemoglobin genetics, pathophysiology, and clinical management
Steinberg, M. H. (2001) · Cited by 438
Identification of a Human Heme Exporter that Is Essential for Erythropoiesis
Quigley, J. G., Yang, Z., Worthington, M. T., Phillips, J. D., Sabo, K. M., Sabath, D. E., Berg, C. L., Sassa, S., Wood, B. L., & Abkowitz, J. L. (2004) · Cell · doi:10.1016/j.cell.2004.08.014 · Cited by 430 · cited 1×
“Previously presented data demonstrate that the absence of heme-regulated inhibitor (HRI) kinase, which controls Hb synthesis (25), exacerbates the β-thalassemia phenotype (26), while lack of heme exporter feline leukemia virus subgroup C cellular receptor (FLVCR), which controls heme export (27), impairs rbc formation…”
BackgroundSurvival and Complications in Thalassemia
BORGNA‐PIGNATTI, C., CAPPELLINI, M. D., DE STEFANO, P., DEL VECCHIO, G. C., FORNI, G. L., GAMBERINI, M. R., GHILARDI, R., ORIGA, R., PIGA, A., ROMEO, M. A., et al. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.006 · Cited by 426 · cited 1×
“NTBI serves as a catalyst for the formation of ROS, which can cause myocyte damage, arrhythmias, and congestive heart failure, the main causes of death in patients with β-thalassemia (22).”
BackgroundIRON ABSORPTION AND LOADING IN β-THALASSÆMIA INTERMEDIA
Pippard, M. J., Warner, G. T., Callender, S. T., & Weatherall, D. J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92175-5 · Cited by 419
A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis
Keel, S. B., Doty, R. T., Yang, Z., Quigley, J. G., Chen, J., Knoblaugh, S., Kingsley, P. D., De Domenico, I., Vaughn, M. B., Kaplan, J., et al. (2008) · Science · doi:10.1126/science.1151133 · Cited by 404
Gardenghi, S., Marongiu, M. F., Ramos, P., Guy, E., Breda, L., Chadburn, A., Liu, Y., Amariglio, N., Rechavi, G., Rachmilewitz, E. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-048868 · Cited by 313 · cited 9×
“were determined as described in our previous publications (8, 26).”
BackgroundMethodInfluentialSelf-citationRegulation of protein synthesis by the heme-regulated eIF2α kinase: relevance to anemias
Chen, J.-J. (2007) · Blood · doi:10.1182/blood-2006-08-041830 · Cited by 305 · cited 2×
“were determined as described in our previous publications (8, 26).”
BackgroundMethodA mouse model for beta 0-thalassemia.
Yang, B., Kirby, S., Lewis, J., Detloff, P. J., Maeda, N., & Smithies, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11608 · Cited by 273 · cited 1×
“The th3/+ mouse, a model of β-thalassemia, harbors a heterozygous deletion of βminor and βmajor genes (5, 6) and exhibits features comparable to those of patients affected by β-thalassemia intermedia, including Hb levels between 7 and 9 g/dl (5–7), IE, EMH, increased production of immature erythroid cells, aberrant er…”
BackgroundRivella, S., May, C., Chadburn, A., Rivière, I., & Sadelain, M. (2003) · Blood · doi:10.1182/blood-2002-10-3305 · Cited by 220 · cited 2×
“poietic fetal liver cells (HFLCs) harvested as described (29).”
BackgroundMethodSelf-citationA mouse model for β-thalassemia
Skow, L. C., Burkhart, B. A., Johnson, F. M., Popp, R. A., Popp, D. M., Goldberg, S. Z., Anderson, W. F., Barnett, L. B., & Lewis, S. E. (1983) · Cell · doi:10.1016/0092-8674(83)90562-7 · Cited by 198
Transferrin therapy ameliorates disease in β-thalassemic mice
Li, H., Rybicki, A. C., Suzuka, S. M., von Bonsdorff, L., Breuer, W., Hall, C. B., Cabantchik, Z. I., Bouhassira, E. E., Fabry, M. E., & Ginzburg, Y. Z. (2010) · Nature Medicine · doi:10.1038/nm.2073 · Cited by 192 · cited 1×
“Recently, th1/th1 mice, a model of β-thalassemia intermedia (23) similar to th3/+, treated with apo-Tf demonstrated a significant reduction of splenomegaly and IE, an increase in Hb and rbc concentrations, and higher hepcidin expression, suggesting that maldistribution of iron in β-thalassemia might also contribute to…”
BackgroundSelf-citationKinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy
Porter, Abeysinghe, R., Marshall, L., Hider, R., & Singh, S. (1996) · Blood · doi:10.1182/blood.v88.2.705.bloodjournal882705 · Cited by 187 · cited 1×
“NTBI in the circulation damages the heart, endocrine organs, and liver (21).”
BackgroundIneffective erythropoiesis and thalassemias
Rivella, S. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832990a4 · Cited by 185 · cited 2×
“Because the main cause of increased iron absorption in β-thalassemia intermedia is the low expression of Hamp1 (13, 14), we utilized transgenic mice overexpressing hepcidin to limit iron overload as a complementary approach to dietary iron restriction.”
BackgroundMethodSelf-citationHepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation
Roy, C. N., Mak, H. H., Akpan, I., Losyev, G., Zurakowski, D., & Andrews, N. C. (2007) · Blood · doi:10.1182/blood-2006-10-051755 · Cited by 178 · cited 4×
“Identification of the endogenous and transgenic mRNAs by Northern blot is possible because Tg-Hamp mRNA contains the β-globin poly(A) sequence instead of the endogenous Hamp1 3′ UTR and poly(A) elements, resulting in an increased length of the transcript (16).”
BackgroundMethodInfluentialSelf-citationA Mouse Model for b-Thalassemia
Lewis, S. E., Barnett, L. B., Anderson, W. F., Goldberg, S. L., Popp, D. M., Popp, R., Johnson, F. M., Burkhart, B., & Skow, L. (1982) · Cited by 172
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in β-thalassemia
Libani, I. V., Guy, E. C., Melchiori, L., Schiro, R., Ramos, P., Breda, L., Scholzen, T., Chadburn, A., Liu, Y., Kernbach, M., et al. (2008) · Blood · doi:10.1182/blood-2007-12-126938 · Cited by 163 · cited 1×
“This observation corroborates previous studies that indicate that β-thalassemic erythroid cells exhibit increased cell proliferation and reduced cell differentiation compared with those from normal mice (20).”
ResultSelf-citationLoss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia
Kong, Y., Zhou, S., Kihm, A. J., Katein, A. M., Yu, X., Gell, D. A., Mackay, J. P., Adachi, K., Foster-Brown, L., Louden, C. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21982 · Cited by 158
Ciavatta, D. J., Ryan, T. M., Farmer, S. C., & Townes, T. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9259 · Cited by 120 · cited 1×
“The th3/+ mouse, a model of β-thalassemia, harbors a heterozygous deletion of βminor and βmajor genes (5, 6) and exhibits features comparable to those of patients affected by β-thalassemia intermedia, including Hb levels between 7 and 9 g/dl (5–7), IE, EMH, increased production of immature erythroid cells, aberrant er…”
BackgroundMechanism of Desferrioxamine‐Induced Iron Excretion in Thalassaemia
Hershko, C., & Rachmilewitz, E. A. (1979) · British Journal of Haematology · doi:10.1111/j.1365-2141.1979.tb03704.x · Cited by 72 · cited 1×
“Increased gastrointestinal iron absorption may also play a role in transfused β-thalassemia major patients, increasing when hemoglobin (Hb) levels decrease (4).”
BackgroundSelf-citationWeizer-Stern, O., Adamsky, K., Amariglio, N., Rachmilewitz, E., Breda, L., Rivella, S., & Rechavi, G. (2006) · American Journal of Hematology · doi:10.1002/ajh.20549 · Cited by 71
Self-citationLiver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
Franceschi, L. D., Daraio, F., Filippini, A., Carturan, S., Muchitsch, E. M., Roetto, A., & Camaschella, C. (2006) · PubMed · Cited by 64
The role of membrane skeletal-associated alpha-globin in the pathophysiology of beta-thalassemia
Sorensen, S., Rubin, E., Polster, H., Mohandas, N., & Schrier, S. (1990) · Blood · doi:10.1182/blood.v75.6.1333.1333 · Cited by 46
Self-citationAbsorption of inorganic and food iron in children with heterozygous and homozygous ?-thalassemia
Heinrich, H. C., Gabbe, E. E., Oppitz, K. H., Whang, D. H., Bender-G�tze, C., Sch�fer, K. H., Schr�ter, W., & Pfau, A. A. (1973) · European Journal of Pediatrics · doi:10.1007/bf00438987 · Cited by 44 · cited 2×
“In the milder form, termed β-thalassemia intermedia, blood transfusions are not always necessary, yet iron overload still occurs due to progressive iron absorption from the gastrointestinal tract (2).”
BackgroundRegulation of Iron Absorption in Hemoglobinopathies
Rechavi, G., & Rivella, S. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241401 · Cited by 35 · cited 2×
“Because the main cause of increased iron absorption in β-thalassemia intermedia is the low expression of Hamp1 (13, 14), we utilized transgenic mice overexpressing hepcidin to limit iron overload as a complementary approach to dietary iron restriction.”
BackgroundMethodSelf-citation
Cited by
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Self-citationGanz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
Self-citationGanz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122
“Unexpectedly, iron overload in mouse models of -thalassemia has a deleterious effect on erythropoiesis that can be reversed by interventions that increase hepcidin production (85, 159).”
BackgroundIdentification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127
Self-citationHepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
Metadata
- Authors
- Gardenghi, S., Ramos, P., Marongiu, M. F., Melchiori, L., Breda, L., Guy, E., Muirhead, K., Rao, N., Roy, C. N., Andrews, N. C., Nemeth, E., Follenzi, A., An, X., Mohandas, N., Ginzburg, Y., Rachmilewitz, E. A., Giardina, P. J., Grady, R. W., & Rivella, S.
- Affiliations
- Weill Cornell Medicine (US)
- Johns Hopkins University (US)
- Duke University (US)
- University of California, Los Angeles (US)
- Albert Einstein College of Medicine (US)
- New York Blood Center (US)
- Wolfson Medical Center (IL)
- Corresponding author
- Rivella, Stefano
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2010-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 4466-4477
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2993583
- OpenAlex
- W2163438420
- Cited by
- 220
- References
- 31
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 6 · 2021: 12 · 2020: 9 · 2019: 19 · 2018: 14 · 2017: 17 · 2016: 13 · 2015: 19 · 2014: 26 · 2013: 21 · 2012: 21
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cooley's Anemia Foundation
- American Portuguese Biomedical Research Fund
- National Institutes of Health (10021)
- College of Veterinary Medicine, Cornell University
- Weill Cornell Medical College
- Fundação para a Ciência e a Tecnologia (SFRH/BD/24813/2005)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK055463, KO1DK065635, R01DK090554, R01DK082717, R01DK55463, K01DK065635)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Keywords
- hepcidin, beta-thalassemia, iron overload, iron absorption, ferroportin, anemia, ineffective erythropoiesis, splenomegaly, reactive oxygen species, red blood cell lifespan, iron metabolism
- MeSH terms
- Animals, Base Sequence, Disease Models, Animal, Erythropoiesis, Humans, Iron, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, Transgenic, Recombinant Proteins, Gene Expression, beta-Thalassemia, DNA Primers, Iron Overload, Iron, Dietary, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.